MiNK Therapeutics Inc (NASDAQ:INKT) Reports Wider Q2 2025 Loss, Advances Clinical Pipeline Amid Market Caution MiNK Therapeutics Q2 2025 earnings miss EPS estimates with a $1.06 loss per share, but cash runway extends to mid-2026. Clinical progress in cancer and GvHD offers future potential.
On Thursday, there are stocks with unusual volume. Let's take a look. In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Which stocks are moving on Tuesday? Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
There are notable gap-ups and gap-downs in today's session. Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
These stocks are moving in today's session Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Which stocks are moving on Monday? Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Let's uncover which stocks are experiencing notable gaps during today's session. Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Monday's pre-market session: top gainers and losers Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
What's going on in today's after hours session Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
